MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$2,527K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Issuance cost
Proceeds from stock options exer...
Increase in other current assets
Others
Negative Cash Flow Breakdown
The amount represents proceeds f...
Proceeds from issuance of common...
Share-based compensation
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-09-30
2025-06-30
Effect of exchange rate changes on cash
-
29
-
Net loss
4,918
-3,200
-5,223
Depreciation
-16
8
15
Share-based compensation
-1,368
927
1,113
The amount of finance income (expenses), net
-14
8
-
Increase in other current assets
-125
-33
252
Decrease (increase) in accounts receivable
-
0
-126
Increase (decrease) in accounts payable
-258
-167
251
The amount of finance expenses, net
-
-
18
Increase (decrease) in accrued liabilities and other operating liabilities
-842
-77
917
Net cash provided by (used in) operating activities
2,447
-2,502
-3,035
Purchase of property and equipment
-80
43
37
Net cash provided by (used in) investing activities
80
-43
-37
Proceeds from issuance of common stock
-6,254
71
6,183
Issuance cost
-262
1
261
The amount represents proceeds from issuance of shares under collaboration agreement
-7,190
0
7,190
Proceeds from stock options exercised
130
-
-
Proceeds from warrant exercises
-354
180
174
Net cash provided by (used in) financing activities
-13,406
250
13,286
Cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), excluding exchange rate effect, including discontinued operation
-10,879
7,919
-
Cash, cash equivalents and restricted deposits at end of the period
16,688
8,740
-
Cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect
-
-
10,214
Cash, cash equivalents and restricted deposits at end of the period
12,017
16,688
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net loss
$4,918K
Purchase of property and
equipment
-$80K
Increase in other current
assets
-$125K
The amount of
finance income...
-$14K
Net cash provided by
(used in) operating...
$2,447K
Net cash provided by
(used in) investing...
$80K
Canceled cashflow
$2,610K
Cash, cash
equivalent, restricted...
-$10,879K
Canceled cashflow
$2,527K
Issuance cost
-$262K
Proceeds from stock
options exercised
$130K
Share-based compensation
-$1,368K
Increase (decrease) in
accrued liabilities and...
-$842K
Increase (decrease) in
accounts payable
-$258K
something is missing
-$126K
Depreciation
-$16K
Net cash provided by
(used in) financing...
-$13,406K
Canceled cashflow
$392K
The amount
represents proceeds from...
-$7,190K
Proceeds from issuance of
common stock
-$6,254K
Proceeds from warrant
exercises
-$354K
Buy us a coffee
Entera Bio Ltd. (ENTXW)
Entera Bio Ltd. (ENTXW)